CHEK2 and breast cancer: In summary, our findings demonstrate that the CHEK2 1100delC occurs at a low frequency in Swedish women with double primary breast cancer and colorectal cancer, and thus suggests that development of these two tumor types is not sufficient to recommend mutation analysis of CHEK2.